Recombinant Human LMW-PTP/ACP1 Protein，GST

Ribonuclease UK114, also known as HRSP12, is a member of the ribonuclease family that has garnered attention due to its potential roles in cellular processes and its therapeutic implications. Initially isolated from the human pancreas, this enzyme is characterized by its ability to degrade RNA substrates, which highlights its significance in RNA metabolism and regulation. Research into HRSP12 has expanded, revealing its involvement in various biological functions, including apoptosis, immune response, and tumor suppression. Given its unique enzymatic properties, HRSP12 has been of particular interest in the development of novel biotherapeutics, especially in the context of highly specific RNA targeting for antiviral and anticancer applications. By utilizing recombinant DNA technology, scientists have been able to produce HRSP12 in a controlled laboratory setting, facilitating in-depth studies of its structure-function relationships and enzymatic mechanisms. This recombinant approach not only allows for the investigation of its potential as a therapeutic agent but also enhances our understanding of its biological roles, paving the way for innovative strategies in disease treatment and intervention. Through ongoing research, the promise of Ribonuclease UK114/HRSP12 continues to be explored, with implications that could extend from basic science to clinical applications.